Join TransPerfect's discussion with industry-experts from Pfizer, Bayer, CodaMetrix, Biogen, BI, Novartis, and Syneos Health about how AI is accelerating changes in the life sciences industry and ways they are leveraging data to support their teams, studies, and products. 

Our discussion will cover the following areas, followed by a Q&A:

- AI in drug discovery

- Predicting adverse events using Natural Language Processing

- Rich patient data and wearable devices

- The computer vision revolution: automated and AI-assisted diagnostics

- Reducing the accessibility barriers to medical information through conversational technologies

- AI and COVID-19 

Our Panelists:

• Gati Dharani, Director, Digital Strategy and Data Innovation, Pfizer
• Mimi Fenton MPH PhD, Executive Director, Real World Evidence & Late Phase, Syneos Health
• Enrico Santus, Senior Data Scientist, Decision Science & Advanced Analytics, Bayer
• Amir Tahmasebi, Senior Director of ML/AI, CodaMetrix
• Antonella Santuccione, CEO WBP and Co-Founder
• Victoria Gamerman, Head of US Health Informatics & Analytics, Boehringer Ingelheim
• Atika Kumar, AI Strategy and Innovation, Novartis

Moderator: Alexandros Poulis, Senior Director, TransPerfect DataForce